(Alliance News) - London stocks were higher around midday on Tuesday, amid warnings for a slowdown in UK economic growth next year and flash PMI readings underperforming against consensus estimates.

Hansa Investment is managed by London-based Hansa Capital Partners LLP, part of the Hanseatic Group. William Salomon chairs the Hanseatic Group, alongside serving as director of Hansa Investment and ...

As of Monday, Airtel Africa said it has returned USD34.7 million of the maximum USD55 million targeted in the second tranche. The revised Barclays arrangement is to repurchase the remaining USD20.3 ...

(Alliance News) - London stocks were mixed at Monday's market open, with miners dominating the top spots on the FTSE 100 index while airlines were hurt after the weekend's alleged cyber attack.

Big Technologies has the view that a drag right exercise was invalid and this will have a "material adverse impact" on its ...

The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:--------- ...

Lexington Gold Ltd - gold explorer, with assets in the US and South Africa - Hails "highly encouraging assay results" from drilling at the Jennings-Pioneer project in South Carolina. In the Barite ...

Spire said: "There can be no certainty either that any offer will be made for the company nor as to the terms of any offer, if made. The company is not in receipt of any approaches and is not in ...

(Alliance News) - Seeen PLC on Thursday reported a narrowed annual loss amid sharp revenue growth which accelerated in the ...

(Alliance News) - SRT Marine Systems PLC on Thursday said it has received notification of the award of significant supply contract with an unnamed, "new sovereign customer", worth around USD200 ...

(Alliance News) - Insig AI PLC on Friday said it is excited by prospects of its existing business and the potential of what it could deliver at scale by investing in new capital, as annual loss ...

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Wednesday said the third patient has been successfully treated in an ongoing phase 1 clinical trial for a form of leukaemia.